Management of malignant pleural effusions

Current Opinion in Pulmonary Medicine. 11(4):296-300, July 2005. [Link] Bennett, Rachel; Maskell, Nick Abstract Abstract: Purpose of review: Although malignant pleural effusions are a common medical problem, research into their optimal management remains sparse. The aim of this review is to summarise recent developments in this area. Recent findings: Talc remains the most efficacious pleurodesis…

Read More

Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients

Lung Cancer. 2005 Jun;48(3):429-34. Epub 2005 Jan 24. [Link] Porta C, Zimatore M, Bonomi L, Imarisio I, Paglino C, Sartore-Bianchi A, Mutti L. Medical Oncology, I.R.C.C.S. San Matteo University Hospital, Piazzale C. Golgi, I-27100 Pavia, Italy. c.porta@smatteo.pv.it Abstract Within a single-institution phase II trial, we investigated the antitumor activity of the Raltitrexed-Oxaliplatin combination as second-line…

Read More